Skip to main content
Bildspel: 

Safeway to add two Kerasal products to majority of stores

Moberg Pharma AB (OMX: MOB) today announced that Safeway has informed Moberg that it plans to add Moberg’s Kerasal Nail Fungal Nail Renewal Treatment and Kerasal Exfoliating Foot Moisturizing Ointment to its stores in March 2014. Moberg estimates distribution at approximately 900 stores. Safeway is an American supermarket chain; it is the second largest supermarket chain in North America, after The Kroger Company and has over 1,300 stores located throughout the western and central United States.

Kerasal Nail is the #1 selling SKU in the food, drug, mass retail market, even without much distribution yet in the food class of trade”, said Steve Cagle, CEO of Moberg Pharma North America, and he continues; “Distribution at Safeway gives Kerasal Nail a strong entry into the food class of trade, and strengthens its distribution on the West Coast. Expanding distribution to grocery chains is consistent with our strategy and further secures Kerasal Nail’s top ranked position in the U.S.

About Moberg Pharma AB
Moberg Pharma AB (publ) is a rapidly growing Swedish pharmaceutical company with its own sales organization in the US and sales through distributors in more than 40 countries. The company’s OTC portfolio includes the brands Kerasal®, Jointflex®, Kerasal Nail™Domeboro®, Vanquish®, Fergon®and Kaprolac®. Kerasal Nail™(Nalox™ in many markets) is the leading product for the treatment of nail disorders in the U.S and Nordic market. The portfolio is developed further through acquisitions and in-licensing of products as well as product development with focus on innovative drug delivery based on proven compounds. Moberg Pharma has offices in Stockholm and New Jersey and the company’s share (OMX: MOB) is listed on the Small Cap list of the NASDAQ OMX Nordic Exchange Stockholm. For further information, please visit: www.mobergpharma.com.